{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:03:36Z","timestamp":1771603416182,"version":"3.50.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Very long-chain acyl-CoA dehydrogenase deficiency (VLCADD) is a rare autosomal recessive disorder of fatty acid metabolism with a variable presentation. The aim of this study was to describe five patients with VLCADD diagnosed through the pilot study and expanded newborn screening (NBS) program that started in 2018 in Slovenia. Four patients were diagnosed through the expanded NBS program with tandem mass spectrometry; one patient was previously diagnosed in a pilot study preceding the NBS implementation. Confirmatory testing consisted of acylcarnitines analysis in dried blood spots, organic acids profiling in urine, genetic analysis of <jats:italic>ACADVL<\/jats:italic> gene, and enzyme activity determination in lymphocytes or fibroblasts. Four newborns with specific elevation of acylcarnitines diagnostic for VLCADD and disease-specific acylcarnitines ratios (C14:1, C14, C14:2, C14:1\/C2, C14:1\/C16) were confirmed with genetic testing: all were compound heterozygotes, two of them had one previously unreported <jats:italic>ACDVL<\/jats:italic> gene variant each (NM_000018.3) c.1538C &amp;gt; G; (NP_000009) p.(Ala513Gly) and c.661A &amp;gt; G; p.(Ser221Gly), respectively. In addition, one patient diagnosed in the pilot study also had a specific elevation of acylcarnitines. Subsequent <jats:italic>ACDVL<\/jats:italic> genetic analysis confirmed compound heterozygosity. In agreement with the diagnosis, enzyme activity was reduced in five patients tested. In seven other newborns with positive screening results, only single allele variants were found in the <jats:italic>ACDVL<\/jats:italic> gene, so the diagnosis was not confirmed. Among these, two variants were novel, c.416T &amp;gt; C and c.1046C &amp;gt; A, respectively (p.Leu139Pro and p.Ala349Glu). In the first 2 years of the expanded NBS program in Slovenia altogether 30,000 newborns were screened. We diagnosed four cases of VLCADD. The estimated VLCADD incidence was 1:7,500 which was much higher than that of the medium-chain acyl-CoA dehydrogenase deficiency (MCADD) cases in the same period. Our study also provided one of the first descriptions of <jats:italic>ACADVL<\/jats:italic> variants in Central-Southeastern Europe and reported on 4 novel variants.<\/jats:p>","DOI":"10.3389\/fgene.2021.648493","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T06:10:43Z","timestamp":1619503843000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: High Incidence of Detected Patients With Expanded Newborn Screening Program"],"prefix":"10.3389","volume":"12","author":[{"given":"Ziga I.","family":"Remec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urh","family":"Groselj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Drole Torkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojca","family":"Zerjav Tansek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanja","family":"Cuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dasa","family":"Perko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanka","family":"Ulaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neza","family":"Lipovec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marusa","family":"Debeljak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jernej","family":"Kovac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadej","family":"Battelino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbka","family":"Repic Lampret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"B1","year":"2021","journal-title":"Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD)."},{"key":"B2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/hmg\/5.4.461","article-title":"Cloning and characterization of human very-long-chain acyl-CoA dehydrogenase cDNA, chromosomal assignment of the gene and identification in four patients of nine different mutations within the VLCAD gene.","volume":"5","author":"Andresen","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1086\/302261","article-title":"Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency.","volume":"64","author":"Andresen","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ymgme.2008.09.008","article-title":"A delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency.","volume":"96","author":"Arnold","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"B5","first-page":"10","article-title":"Program pro\u0161irenog novoro\u00f0ena\u010dkog probira u Republici Hrvatskoj \u2013 zahtjevi i izazovi pravilnog uzimanja suhe kapi krvi.","volume":"62","author":"Biland\u017eija","year":"2018","journal-title":"Paediatr. Croat."},{"key":"B6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/jimd.12075","article-title":"Impact of newborn screening for very-long-chain acyl-CoA dehydrogenase deficiency on genetic, enzymatic, and clinical outcomes.","volume":"42","author":"Bleeker","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"100634","DOI":"10.1016\/j.ymgmr.2020.100634","article-title":"False positive cases of elevated tetradecenoyl carnitine in newborn mass screening showed significant loss of body weight.","volume":"24","author":"Bo","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ymgme.2005.12.012","article-title":"VLCAD deficiency: pitfalls in newborn screening and confirmation of diagnosis by mutation analysis.","volume":"88","author":"Boneh","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/gim.2015.22","article-title":"Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.","volume":"17","author":"Diekman","year":"2015","journal-title":"Genet. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1111\/ene.14402","article-title":"Adult-onset very-long-chain acyl-CoA dehydrogenase deficiency (VLCADD).","volume":"27","author":"Fatehi","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ymgme.2014.07.019","article-title":"Fifty years of phenylketonuria newborn screening \u2013 a great success for many, but what about the rest?","volume":"113","author":"Groselj","year":"","journal-title":"Mol. Genet. Metab."},{"key":"B12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ymgme.2014.07.020","article-title":"Newborn screening in southeastern Europe.","volume":"113","author":"Groselj","year":"","journal-title":"Mol. Genet. Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.gim.0000204472.25153.8d","article-title":"The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update.","volume":"8","author":"Grosse","year":"2006","journal-title":"Genet. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s10545-018-0245-5","article-title":"The diagnostic challenge in very-long chain acyl-CoA dehydrogenase deficiency (VLCADD).","volume":"41","author":"Hesse","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1620\/tjem.235.305","article-title":"A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.","volume":"235","author":"Hisahara","year":"2015","journal-title":"Tohoku J. Exp. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10545-011-9391-8","article-title":"VLCAD enzyme activity determinations in newborns identified by screening: a valuable tool for risk assessment.","volume":"35","author":"Hoffmann","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2478\/jomb-2014-0056","article-title":"Selective screening for metabolic disorders in the slovenian pediatric population.","volume":"34","author":"Lampret","year":"2015","journal-title":"J. Med. Biochem."},{"key":"B18","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2478\/sjph-2020-0032","article-title":"Expanded newborn screening program in slovenia using tandem mass spectrometry and confirmatory next generation sequencing genetic testing.","volume":"59","author":"Lampret","year":"2020","journal-title":"Zdr. Varst."},{"key":"B19","article-title":"Very long-chain acyl-coenzyme a dehydrogenase deficiency","author":"Leslie","year":"1993","journal-title":"GeneReviews<sup>\u00ae<\/sup>"},{"key":"B20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10545-010-9076-8","article-title":"Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting.","volume":"33","author":"Lindner","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ijns7010015","article-title":"Neonatal screening in europe revisited: an ISNS perspective on the current state and developments since 2010.","volume":"7","author":"Loeber","year":"2021","journal-title":"Int. J. Neonatal. Screen."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-020-01070-0","article-title":"Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders.","author":"Marsden","year":"2021","journal-title":"Genet. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/0006-291x(90)91421-n","article-title":"Identification of a common mutation in patients with medium-chain acyl-CoA dehydrogenase deficiency.","volume":"171","author":"Matsubara","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ymgme.2014.01.009","article-title":"Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening.","volume":"111","author":"Merritt","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"B25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ymgme.2015.08.011","article-title":"Recurrent ACADVL molecular findings in individuals with a positive newborn screen for very long chain acyl-coA dehydrogenase (VLCAD) deficiency in the United States.","volume":"116","author":"Miller","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"B26","year":"2020","journal-title":"Medium Chain Acyl CoA Dehydrogenase Deficiency."},{"key":"B27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ymgme.2016.05.007","article-title":"Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-IS database.","volume":"118","author":"Pena","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s10545-006-0292-1","article-title":"Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: a global perspective.","volume":"29","author":"Rhead","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ymgme.2019.04.001","article-title":"Clinical and biochemical outcome of patients with very long-chain acyl-CoA dehydrogenase deficiency.","volume":"127","author":"Rovelli","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1002\/9781119467205","author":"Shaw","year":"2020","journal-title":"Clinical Paediatric Dietetics."},{"key":"B32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1515\/sjph-2015-0013","article-title":"Newborn screening in slovenia.","volume":"54","author":"\u0160mon","year":"2015","journal-title":"Zdr. Varst."},{"key":"B33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clinbiochem.2017.10.016","article-title":"Next generation sequencing as a follow-up test in an expanded newborn screening programme.","volume":"52","author":"Smon","year":"2018","journal-title":"Clin. Biochem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10545-010-9090-x","article-title":"Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening.","volume":"33","author":"Spiekerkoetter","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s10545-009-1126-8","article-title":"Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop.","volume":"32","author":"Spiekerkoetter","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"10496","DOI":"10.1073\/pnas.92.23.10496","article-title":"Molecular basis of human mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency causing cardiomyopathy and sudden death in childhood.","volume":"92","author":"Strauss","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B37","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1203\/PDR.0b013e318187cc44","article-title":"Development of a new enzymatic diagnosis method for very-long-chain Acyl-CoA dehydrogenase deficiency by detecting 2-hexadecenoyl-CoA production and its application in tandem mass spectrometry-based selective screening and newborn screening in Japan.","volume":"64","author":"Tajima","year":"2008","journal-title":"Pediatr. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ymgme.2020.10.001","article-title":"Nutrition management guideline for very-long chain acyl-CoA dehydrogenase deficiency (VLCAD): an evidence- and consensus-based approach.","volume":"131","author":"Van Calcar","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"B39","year":"2020","journal-title":"Very Long Chain Acyl CoA Dehydrogenase Deficiency (LCAD)."},{"key":"B40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/s0009-8981(97)00185-x","article-title":"Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients.","volume":"269","author":"Vianey-Saban","year":"1998","journal-title":"Clin. Chim. Acta"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1056\/NEJMoa025225","article-title":"Screening newborns for inborn errors of metabolism by tandem mass spectrometry.","volume":"348","author":"Wilcken","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B42","year":"2020","journal-title":"WMA Declaration of Helsinki \u2013 Ethical Principles for Medical Research Involving Human Subjects."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.648493\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T06:10:50Z","timestamp":1619503850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.648493\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":42,"alternative-id":["10.3389\/fgene.2021.648493"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2021.648493","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,27]]},"article-number":"648493"}}